Correlation between small and dense low-density lipoprotein cholesterol and cardiovascular events in Beijing community population

被引:9
作者
Wang, Xiaona [1 ]
Wang, Liang [1 ]
Cao, Ruihua [1 ]
Yang, Xu [1 ]
Xiao, Wenkai [1 ]
Zhang, Yun [1 ]
Ye, Ping [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Dept Geriatr Cardiol, Beijing, Peoples R China
关键词
coronary disease; epidemiology; lipids; major adverse cardiovascular events; sdLDL-C;
D O I
10.1111/jch.14150
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The relationship between small dense low-density lipoprotein cholesterol (sdLDL-C) and different cardiovascular events has been observed in several large community studies, and the results have been controversial. However, there is currently no cross-sectional or longitudinal follow-up study on sdLDL-C in the Chinese hypertension population. We analyzed the association of plasma sdLDL-C levels with major adverse cardiovascular events in 1325 subjects from a longitudinal follow-up community-based population in Beijing, China. During the follow-up period, a total of 191 subjects had MACEs. Cox regression analysis showed that sdLDL-C is a major risk factor for MACEs independent of sex, age, BMI, hypertension, diabetes, smoking, SBP, DBP, FBG, eGFR in the general community population (1.013 (1.001 -1.025, P < .05)), but the correlation disappeared after adjusting for TC and HDL-C in Model 3. Cox analysis showed that hypertension combined with high level of sdLDL-C was still the risk factor for MACEs ((2.079 (1.039-4.148)). Our findings in the Chinese cohort support that sdLDL-C is a risk factor for major adverse cardiovascular events in hypertension subjects.
引用
收藏
页码:345 / 351
页数:7
相关论文
共 34 条
  • [1] Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials
    Afilalo, Jonathan
    Majdan, Agnieska A.
    Eisenberg, Mark J.
    [J]. HEART, 2007, 93 (08) : 914 - 921
  • [2] Small dense low-density lipoprotein-lowering agents
    Alizadeh-Fanalou, Shahin
    Nazarizadeh, Ali
    Alian, Fatemeh
    Faraji, Parisa
    Sorori, Bahareh
    Khosravi, Mohsen
    [J]. BIOLOGICAL CHEMISTRY, 2020, 401 (10) : 1101 - 1121
  • [3] Small Dense Low-Density Lipoproteins Cholesterol can Predict Incident Cardiovascular Disease in an Urban Japanese Cohort: The Suita Study
    Arai, Hidenori
    Kokubo, Yoshihiro
    Watanabe, Makoto
    Sawamura, Tatsuya
    Ito, Yasuki
    Minagawa, Asako
    Okamura, Tomonori
    Miyamato, Yoshihiro
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2013, 20 (02) : 195 - 203
  • [4] AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
  • [5] BIMODALITY OF PLASMA APOLIPOPROTEIN-B LEVELS IN FAMILIAL COMBINED HYPERLIPIDEMIA
    AUSTIN, MA
    HOROWITZ, H
    WIJSMAN, E
    KRAUSS, RM
    BRUNZELL, J
    [J]. ATHEROSCLEROSIS, 1992, 92 (01) : 67 - 77
  • [6] Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined Hyperlipidemia
    Ayyobi, AF
    McGladdery, SH
    McNeely, MJ
    Austin, MA
    Motulsky, AG
    Brunzell, JD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) : 1289 - 1294
  • [7] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [8] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    Baigent, C
    Keech, A
    Kearney, PM
    Blackwell, L
    Buck, G
    Pollicino, C
    Kirby, A
    Sourjina, T
    Peto, R
    Collins, R
    Simes, J
    [J]. LANCET, 2005, 366 (9493) : 1267 - 1278
  • [9] Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes
    Berneis, K
    Jeanneret, C
    Muser, E
    Felix, B
    Miserez, AR
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (02): : 227 - 234
  • [10] Cao, 2020, J HYPERTENS, V11